{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["gene OPG", "osteoporosis", "osteoprotegerin", "polymorphism", "postmenopausal women"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "38137439", "DateRevised": {"Year": "2023", "Month": "12", "Day": "25"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "12", "Day": "04"}], "Language": ["eng"], "ELocationID": ["3218", "10.3390/biomedicines11123218"], "Journal": {"ISSN": "2227-9059", "JournalIssue": {"Volume": "11", "Issue": "12", "PubDate": {"Year": "2023", "Month": "Dec", "Day": "04"}}, "Title": "Biomedicines", "ISOAbbreviation": "Biomedicines"}, "ArticleTitle": "Osteoprotegerin Gene as a Biomarker in the Development of Osteoporosis in Postmenopausal Women.", "Abstract": {"AbstractText": ["Osteoporosis is a multifactorial and polygenic disease caused by an imbalance between osteoclastogenesis and osteoblastogenesis, leading to a decrease in bone mineral density and the occurrence of disorders in the microarchitecture and metabolism of bone tissue. In postmenopausal women, there is a significant decrease in the production of estrogens, which play a key role in maintaining proper bone mineral density. Estrogens have an inhibitory effect on the development and activity of osteoclasts by reducing the synthesis of pro-resorption cytokines and stimulating the expression of osteoprotegerin (OPG). Osteoprotegerin is a cytokine that prevents bone loss by inhibiting the process of osteoclastogenesis, reducing bone resorption. The aim of our study was to determine the influence of the rs3102735 (-163A>G), rs3134070 (-245T>G), rs207361 (-950T>C), rs7844539 (6890A>C), and rs2073618 (1181G>C) polymorphisms of the <i>OPG</i> gene on the risk of osteoporosis and osteopenia in postmenopausal Polish women. The study included 802 unrelated women (osteoporosis: <i>n</i> = 317, osteopenia: <i>n</i> = 110, controls: <i>n</i> = 375) at postmenopausal age (54.7 \u00b1 8.6 years). Genetic analysis was performed using real-time PCR. BMD values as well as clinical and bone parameters with the tested polymorphisms were analyzed among the study population. Analysis of the <i>PPARG</i> rs1801282 variants did not show any association with the risk of osteoporosis and osteopenia. However, for the <i>OPG</i> rs207361 polymorphism, we observed a statistically significant association with the risk of osteoporosis, suggesting that the <i>OPG</i> rs207361 variant may be one of the genetic markers associated with the pathogenesis of osteoporosis."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Pharmacoeconomics, Pomeranian Medical University in Szczecin, 71-230 Szczecin, Poland."}], "LastName": "Przerwa", "ForeName": "Filip", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Pharmacoeconomics, Pomeranian Medical University in Szczecin, 71-230 Szczecin, Poland."}], "LastName": "Uzar", "ForeName": "Izabela", "Initials": "I"}, {"Identifier": ["0000-0001-5455-8315"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Personalized Medicine and Cell Therapy, Regional Blood Center, Marceli\u0144ska 44, 60-354 Poznan, Poland."}], "LastName": "Bogacz", "ForeName": "Anna", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of General and Dental Radiology, Pomeranian Medical University in Szczecin, al. Powsta\u0144c\u00f3w Wielkopolskch 72, 70-111 Szczecin, Poland."}], "LastName": "Kotrych", "ForeName": "Katarzyna", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "General, Mini-Invasive and Gastroenterogical Surgery Clinic, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland."}], "LastName": "Sulikowski", "ForeName": "Tadeusz", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Stem Cells and Regenerative Medicine, Institute of Natural Fibres and Medicinal Plants, Kolejowa 2, 62-064 Plewiska, Poland."}], "LastName": "Wolek", "ForeName": "Marlena", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Orthopaedics and Traumatology, Independent Public Clinical Hospital No. 1, Pomeranian Medical University in Szczecin, Unii Lubelskiej 1, 71-252 Szczecin, Poland."}], "LastName": "Kami\u0144ski", "ForeName": "Adam", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Orthopaedics, Traumatology and Orthopaedic Oncology, Pomeranian Medical University, Unii Lubelskiej 1, 71-252 Szczecin, Poland."}], "LastName": "Zi\u0119tek", "ForeName": "Pawe\u0142", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Pharmacoeconomics, Pomeranian Medical University in Szczecin, 71-230 Szczecin, Poland."}, {"Identifier": [], "Affiliation": "Department of Stem Cells and Regenerative Medicine, Institute of Natural Fibres and Medicinal Plants, Kolejowa 2, 62-064 Plewiska, Poland."}], "LastName": "Czerny", "ForeName": "Bogus\u0142aw", "Initials": "B"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Biomedicines", "NlmUniqueID": "101691304", "ISSNLinking": "2227-9059"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "S\u00f6zen T., \u00d6z\u0131\u015f\u0131k L., Ba\u015faran N.\u00c7. An overview and management of osteoporosis. Eur. J. Rheumatol. 2017;4:46\u201356. doi: 10.5152/eurjrheum.2016.048.", "ArticleIdList": ["10.5152/eurjrheum.2016.048", "PMC5335887", "28293453"]}, {"Citation": "Simonet W.S., Lacey D.L., Dunstan C.R., Kelley M., Chang M.S., Luthy R., Nguyen H.Q., Wooden S., Bennett L., Boone T., et al. Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone Density. Cell. 1997;89:309\u2013319. doi: 10.1016/S0092-8674(00)80209-3.", "ArticleIdList": ["10.1016/S0092-8674(00)80209-3", "9108485"]}, {"Citation": "Feng X. RANKing Intracellular Signaling in Osteoclasts. IUBMB Life. 2005;57:389\u2013395. doi: 10.1080/15216540500137669.", "ArticleIdList": ["10.1080/15216540500137669", "16012047"]}, {"Citation": "Arko B., Pre\u017eelj J., Kocijan\u010di\u010d A., Komel R., Marc J. Association of the osteoprotegerin gene polymorphisms with bone mineral density in postmenopausal women. Maturitas. 2005;51:270\u2013279. doi: 10.1016/j.maturitas.2004.08.006.", "ArticleIdList": ["10.1016/j.maturitas.2004.08.006", "15978970"]}, {"Citation": "Pettit A.R., Ji H., von Stechow D., M\u00fcller R., Goldring S.R., Choi Y., Benoist C., Gravallese E.M. TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis. Am. J. Pathol. 2001;159:1689\u20131699. doi: 10.1016/S0002-9440(10)63016-7.", "ArticleIdList": ["10.1016/S0002-9440(10)63016-7", "PMC1867076", "11696430"]}, {"Citation": "Yasuda H., Shima N., Nakagawa N., Mochizuki S.-I., Yano K., Fujise N., Sato Y., Goto M., Yamaguchi K., Kuriyama M., et al. Identity of Osteoclastogenesis Inhibitory Factor (OCIF) and Osteoprotegerin (OPG): A Mechanism by which OPG/OCIF Inhibits Osteoclastogenesis in vitro. Endocrinology. 1998;139:1329\u20131337. doi: 10.1210/endo.139.3.5837.", "ArticleIdList": ["10.1210/endo.139.3.5837", "9492069"]}, {"Citation": "Kostenuik P., Shalhoub V. Osteoprotegerin A Physiological and Pharmacological Inhibitor of Bone Resorption. Curr. Pharm. Des. 2001;7:613\u2013635. doi: 10.2174/1381612013397807.", "ArticleIdList": ["10.2174/1381612013397807", "11375772"]}, {"Citation": "Th\u00e9oleyre S., Tat S.K., Vusio P., Blanchard F., Gallagher J., Ricard-Blum S., Fortun Y., Padrines M., R\u00e9dini F., Heymann D. Characterization of osteoprotegerin binding to glycosaminoglycans by surface plasmon resonance: Role in the interactions with receptor activator of nuclear factor \u03baB ligand (RANKL) and RANK. Biochem. Biophys. Res. Commun. 2006;347:460\u2013467. doi: 10.1016/j.bbrc.2006.06.120.", "ArticleIdList": ["10.1016/j.bbrc.2006.06.120", "16828054"]}, {"Citation": "Nair S., Bhadricha H., Patil A., Surve S., Joshi B., Balasinor N., Desai M. Association of OPG and RANKL gene polymorphisms with bone mineral density in Indian women. Gene. 2022;840:146746. doi: 10.1016/j.gene.2022.146746.", "ArticleIdList": ["10.1016/j.gene.2022.146746", "35868414"]}, {"Citation": "Han X., Zheng L., Mu Y.-Y., Li H.-Z., He X.-F. Association between OPG polymorphisms and osteoporosis risk: An updated meta-analysis. Front. Genet. 2022;13:1032110. doi: 10.3389/fgene.2022.1032110.", "ArticleIdList": ["10.3389/fgene.2022.1032110", "PMC9682267", "36437941"]}, {"Citation": "Tariq S., Tariq S., Abualhamael S.A., Baig M., Malik A.A., Shahzad M. Osteoprotegerin genetic polymorphisms and their influence on therapeutic response to ibandronate in postmenopausal osteoporotic females. PLoS ONE. 2023;18:e0291959. doi: 10.1371/journal.pone.0291959.", "ArticleIdList": ["10.1371/journal.pone.0291959", "PMC10521989", "37751449"]}, {"Citation": "Kim G.S., Koh J.M., Chang J.S., Park B.L., Kim L.H., Park E.K., Kim S.-Y., Shin H.D. Association of the OSCAR Promoter Polymorphism with BMD in Postmenopausal Women: Oscar polymorphism and BMD. J. Bone Miner. Res. 2005;20:1342\u20131348. doi: 10.1359/JBMR.050320.", "ArticleIdList": ["10.1359/JBMR.050320", "16007331"]}, {"Citation": "Wu Z.Z., Liu M. The effect of low-body weight combined with T149C and A163G polymorphism of osteoprotegerin promoter region on osteoporosis. Chin. J. Geriatr. 2006;25:645\u2013650."}, {"Citation": "Garc\u00eda-Unzueta M.T., Riancho J.A., Zarrabeitia M.T., Sa\u00f1udo C., Berja A., Valero C., Pesquera C., Paule B., Gonz\u00e1lez-Mac\u00edas J., Amado J.A. Association of the 163A/G and 1181G/C Osteoprotegerin Polymorphism with Bone Mineral Density. Horm. Metab. Res. 2008;40:219\u2013224. doi: 10.1055/s-2008-1046793.", "ArticleIdList": ["10.1055/s-2008-1046793", "18348083"]}, {"Citation": "Brambila-Tapia A.J.L., Dur\u00e1n-Gonz\u00e1lez J., Sandoval-Ram\u00edrez L., Mena J.P., Salazar-P\u00e1ramo M., G\u00e1mez-Nava J.I., Gonz\u00e1lez-L\u00f3pez L., Lazalde-Medina B.B., D\u00e1valos N.O., Peralta-Leal V., et al. MTHFR C677T, MTHFR A1298C, and OPG A163G Polymorphisms in Mexican Patients with Rheumatoid Arthritis and Osteoporosis. Dis. Markers. 2012;32:109\u2013114. doi: 10.1155/2012/364894.", "ArticleIdList": ["10.1155/2012/364894", "PMC3826806", "22377704"]}, {"Citation": "Boro\u0144 D., Kotrych D., Bartkowiak-Wieczorek J., Uzar I., Bogacz A., Kami\u0144ski A. Polymorphisms of OPG and their relation to the mineral density of bones in pre- and postmenopausal women. Int. Immunopharmacol. 2015;28:477\u2013486. doi: 10.1016/j.intimp.2015.07.015.", "ArticleIdList": ["10.1016/j.intimp.2015.07.015", "26202809"]}, {"Citation": "Bonf\u00e1 A.C., Seguro L.P.C., Caparbo V., Bonf\u00e1 E., Pereira R.M.R. RANKL and OPG gene polymorphisms: Associations with vertebral fractures and bone mineral density in premenopausal systemic lupus erythematosus. Osteoporos. Int. 2015;26:1563\u20131571. doi: 10.1007/s00198-015-3029-x.", "ArticleIdList": ["10.1007/s00198-015-3029-x", "25609157"]}, {"Citation": "Bla\u0161\u010d\u00e1kov\u00e1 M.M., Bla\u0161\u010d\u00e1kov\u00e1 \u013d., Por\u00e1\u010dov\u00e1 J., Mydl\u00e1r J., Va\u0161kov\u00e1 J., Bernasovsk\u00e1 J., Boro\u0148ov\u00e1 I., Petrej\u010d\u00edkov\u00e1 E., Bernasovsk\u00fd I. Relationship between A163G osteoprotegerin gene polymorphism and other osteoporosis parameters in Roma and non-Roma postmenopausal women in eastern Slovakia. J. Clin. Lab. Anal. 2017;31:22093. doi: 10.1002/jcla.22093.", "ArticleIdList": ["10.1002/jcla.22093", "PMC6816896", "27859736"]}, {"Citation": "Abdi S., Binbaz R.A., Mohammed A.K., Ansari M.G., Wani K., Amer O.E., Alnaami A.M., Aljohani N., Al-Daghri N.M. Association of RANKL and OPG Gene Polymorphism in Arab Women with and without Osteoporosis. Genes. 2021;12:200. doi: 10.3390/genes12020200.", "ArticleIdList": ["10.3390/genes12020200", "PMC7910965", "33572979"]}, {"Citation": "Langdahl B.L., Carstens M., Stenkjaer L., Eriksen E.F. Polymorphisms in the Osteoprotegerin Gene Are Associated With Osteoporotic Fractures. J. Bone Miner. Res. 2002;17:1245\u20131255. doi: 10.1359/jbmr.2002.17.7.1245.", "ArticleIdList": ["10.1359/jbmr.2002.17.7.1245", "12096838"]}, {"Citation": "Kusk P., Madsen B., Fenger M., Lauritzen J.B., J\u00f8rgensen H.L. Serum osteoprotegerin (OPG) and the A163G polymorphism in the OPG promoter region are related to peripheral measures of bone mass and fracture odds ratios. J. Bone Miner. Metab. 2004;22:132\u2013138. doi: 10.1007/s00774-003-0461-3.", "ArticleIdList": ["10.1007/s00774-003-0461-3", "14999524"]}, {"Citation": "Hsu Y.-H., Niu T., Terwedow H.A., Xu X., Feng Y., Li Z., Brain J.D., Rosen C.J., Laird N., Xu X. Variation in genes involved in the RANKL/RANK/OPG bone remodeling pathway are associated with bone mineral density at different skeletal sites in men. Hum. Genet. 2006;118:568\u2013577. doi: 10.1007/s00439-005-0062-4.", "ArticleIdList": ["10.1007/s00439-005-0062-4", "16249885"]}, {"Citation": "Seremak-Mrozikiewicz A., Tatu\u015bko J., Drews K., Barlik M., Krajewski P., Spaczy\u0144ski M., Mrozikiewicz P.M. Polymorphism of osteoprotegerin gene and osteoporosis in postmenopausal women. Ginekol. Pol. 2009;80:354\u2013360.", "ArticleIdList": ["19548455"]}, {"Citation": "Hussien Y.M., Shehata A., Karam R.A., Alzahrani S.S., Magdy H., El-Shafey A.M. Polymorphism in vitamin D receptor and osteoprotegerin genes in Egyptian rheumatoid arthritis patients with and without osteoporosis. Mol. Biol. Rep. 2013;40:3675\u20133680. doi: 10.1007/s11033-012-2443-9.", "ArticleIdList": ["10.1007/s11033-012-2443-9", "23271131"]}, {"Citation": "Cvijetic S., Grazio S., Kosovic P., Uremovic M., Nemcic T., Bobic J. Osteoporosis and polymorphisms of osteoprotegerin gene in postmenopausal women\u2014A pilot study. Rheumatology. 2016;54:10\u201313. doi: 10.5114/reum.2016.58755.", "ArticleIdList": ["10.5114/reum.2016.58755", "PMC4847329", "27407270"]}, {"Citation": "Wu Z.Z., Feng J.Q., Liu M., Lin W., Huang Y., Shi Q.W. The relationship between body fat ratio combined with G209A and T245G polymorphism of osteoprotegerin promoter region and osteoporosis. Chin. J. Geriatr. 2007;12:2409\u20132413."}, {"Citation": "Kim J.G., Kim J.H., Kim J.Y., Ku S.Y., Jee B.C., Suh C.S., Kim S.H., Choi Y.M. Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women. Menopause. 2007;14:913\u2013918. doi: 10.1097/gme.0b013e31802d976f.", "ArticleIdList": ["10.1097/gme.0b013e31802d976f", "17667143"]}, {"Citation": "Mencej-Bedra\u010d S., Pre\u017eelj J., Marc J. TNFRSF11B gene polymorphisms 1181G>C and 245T>G as well as haplotype CT influence bone mineral density in postmenopausal women. Maturitas. 2011;69:263\u2013267. doi: 10.1016/j.maturitas.2011.02.010.", "ArticleIdList": ["10.1016/j.maturitas.2011.02.010", "21411255"]}, {"Citation": "Zavala-Cerna M.G., Moran-Moguel M.C., Cornejo-Toledo J.A., Gonzalez-Montoya N.G., Sanchez-Corona J., Salazar-Paramo M., Nava-Zavala A.H., Aguilar-Chavez E.A., Alcaraz-Lopez M.F., Gonzalez-Sanchez A.G., et al. Osteoprotegerin Polymorphisms in a Mexican Population with Rheumatoid Arthritis and Generalized Osteoporosis: A Preliminary Report. J. Immunol. Res. 2015;2015:376197. doi: 10.1155/2015/376197.", "ArticleIdList": ["10.1155/2015/376197", "PMC4433710", "26065000"]}, {"Citation": "Zaj\u00ed\u010dkov\u00e1 K., Zemanov\u00e1 A., Hill M., \u017dofkov\u00e1 I. Is A163G polymorphism in the osteoprotegerin gene associated with heel velocity of sound in postmenopausal women? Physiol. Res. 2008;57((Suppl. S1)):153\u2013157. doi: 10.33549/physiolres.931500.", "ArticleIdList": ["10.33549/physiolres.931500", "18271681"]}, {"Citation": "Wu Z.Z., Liu M., Feng J.Q. Relationships among single T~(950) -C mutation polymorphism in the promoter region of the osteoprotegerin gene, bone mineral density and metabolism. Chin. J. Geriatr. 2005;3:247\u2013250."}, {"Citation": "Vidal N., Brandstrom H., Jonsson K., Ohlsson C. Osteoprotegerin mRNA is expressed in primary human osteoblast-like cells: Down-regulation by glucocorticoids. J. Endocrinol. 1998;159:191\u2013195. doi: 10.1677/joe.0.1590191.", "ArticleIdList": ["10.1677/joe.0.1590191", "9795357"]}, {"Citation": "Wynne F., Drummond F., O\u2019Sullivan K., Daly M., Shanahan F., Molloy M., Quane K. Investigation of the Genetic Influence of the OPG, VDR (Fok1), and COLIA1 Sp1 Polymorphisms on BMD in the Irish Population. Calcif. Tissue Int. 2002;71:26\u201335. doi: 10.1007/s00223-001-2081-z.", "ArticleIdList": ["10.1007/s00223-001-2081-z", "12073153"]}, {"Citation": "Vidal C., Brincat M., Anastasi A.X. TNFRSF11B gene variants and bone mineral density in postmenopausal women in Malta. Maturitas. 2006;53:386\u2013395. doi: 10.1016/j.maturitas.2005.11.003.", "ArticleIdList": ["10.1016/j.maturitas.2005.11.003", "16343827"]}, {"Citation": "Ueland T., Bollerslev J., Wilson S., Dick I., Islam F., Mullin B., Devine A., Prince R. No associations between OPG gene polymorphisms or serum levels and measures of osteoporosis in elderly Australian women. Bone. 2007;40:175\u2013181. doi: 10.1016/j.bone.2006.06.022.", "ArticleIdList": ["10.1016/j.bone.2006.06.022", "16949901"]}, {"Citation": "Lee Y.H., Woo J.-H., Choi S.J., Ji J.D., Song G.G. Associations between osteoprotegerin polymorphisms and bone mineral density: A meta-analysis. Mol. Biol. Rep. 2010;37:227\u2013234. doi: 10.1007/s11033-009-9637-9.", "ArticleIdList": ["10.1007/s11033-009-9637-9", "19642016"]}, {"Citation": "Guo L., Tang K., Quan Z., Zhao Z., Jiang D. Association Between Seven Common OPG Genetic Polymorphisms and Osteoporosis Risk: A Meta-Analysis. DNA Cell Biol. 2014;33:29\u201339. doi: 10.1089/dna.2013.2206.", "ArticleIdList": ["10.1089/dna.2013.2206", "24283361"]}, {"Citation": "Li S., Jiang H., Du N. Association between osteoprotegerin gene T950C polymorphism and osteoporosis risk in the Chinese population: Evidence via meta-analysis. PLoS ONE. 2017;12:e0189825. doi: 10.1371/journal.pone.0189825.", "ArticleIdList": ["10.1371/journal.pone.0189825", "PMC5734735", "29253005"]}, {"Citation": "Nava-Valdivia C.A., Salda\u00f1a-Cruz A.M., Corona-Sanchez E.G., Murillo-Vazquez J.D., Moran-Moguel M.C., Salazar-Paramo M., Perez-Guerrero E.E., Vazquez-Villegas M.L., Bonilla-Lara D., Rocha-Mu\u00f1oz A.D., et al. Polymorphism rs2073618 of the TNFRSF11B (OPG) Gene and Bone Mineral Density in Mexican Women with Rheumatoid Arthritis. J. Immunol. Res. 2017;2017:7680434. doi: 10.1155/2017/7680434.", "ArticleIdList": ["10.1155/2017/7680434", "PMC5516719", "28758134"]}, {"Citation": "Gonz\u00e1lez-Mercado A., S\u00e1nchez-L\u00f3pez J.Y., Perea-D\u00edaz F.J., Maga\u00f1a-Torres M.T., Salazar-P\u00e1ramo M., Gonz\u00e1lez-L\u00f3pez L., Gonz\u00e1lez-Mercado M.G., Ibarra-Cort\u00e9s B. Association of polymorphisms of the TNFRSF11B and TNFSF11 genes with bone mineral density in postmenopausal women from western Mexico. Arch. Med. Sci. 2019;15:1352\u20131356. doi: 10.5114/aoms.2019.87410.", "ArticleIdList": ["10.5114/aoms.2019.87410", "PMC6764302", "31572484"]}, {"Citation": "Choi J.Y., Shin A., Park S.K., Chung H.W., Cho S., Shin C.S., Kim H., Lee K.H., Kang C., Cho D.Y., et al. Genetic Polymorphisms of OPG, RANK, and ESR1 and Bone Mineral Density in Korean Postmenopausal Women. Calcif. Tissue Int. 2005;77:152\u2013159. doi: 10.1007/s00223-004-0264-0.", "ArticleIdList": ["10.1007/s00223-004-0264-0", "16151677"]}, {"Citation": "Moffett S.P., Oakley J.I., Cauley J.A., Lui L.Y., Ensrud K.E., Taylor B.C., Hillier T.A., Hochberg M.C., Li J., Cayabyab S., et al. Osteoprotegerin Lys3Asn Polymorphism and the Risk of Fracture in Older Women. J. Clin. Endocrinol. Metab. 2008;93:2002\u20132008. doi: 10.1210/jc.2007-1019.", "ArticleIdList": ["10.1210/jc.2007-1019", "PMC2386283", "18319311"]}, {"Citation": "Tu P., Duan P., Zhang R.-S., Xu D.-B., Wang Y., Wu H.-P., Liu Y.-H., Si L. Polymorphisms in genes in the RANKL/RANK/OPG pathway are associated with bone mineral density at different skeletal sites in post-menopausal women. Osteoporos. Int. 2014;26:179\u2013185. doi: 10.1007/s00198-014-2854-7.", "ArticleIdList": ["10.1007/s00198-014-2854-7", "25138264"]}, {"Citation": "Canto-Cetina T., Reyes L.P., Herrera L.G., Rojano-Mej\u00eda D., Coral-V\u00e1zquez R.M., Coronel A., Canto P. Polymorphism of LRP5, but not of TNFRSF11B, is associated with a decrease in bone mineral density in postmenopausal maya-mestizo women. Am. J. Hum. Biol. 2013;25:713\u2013718. doi: 10.1002/ajhb.22464.", "ArticleIdList": ["10.1002/ajhb.22464", "24130145"]}, {"Citation": "Rojano-Mej\u00eda D., Coral-V\u00e1zquez R.M., Espinosa L.C., Romero-Hidalgo S., L\u00f3pez-Medina G., del Carmen Aguirre Garc\u00eda M., Coronel A., Ibarra R., Canto P. TNFRSF11B gene haplotype and its association with bone mineral density variations in postmenopausal Mexican-Mestizo women. Maturitas. 2012;71:49\u201354. doi: 10.1016/j.maturitas.2011.10.009.", "ArticleIdList": ["10.1016/j.maturitas.2011.10.009", "22079369"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "11", "Day": "2"}, {"Year": "2023", "Month": "11", "Day": "27"}, {"Year": "2023", "Month": "12", "Day": "1"}, {"Year": "2023", "Month": "12", "Day": "23", "Hour": "12", "Minute": "45"}, {"Year": "2023", "Month": "12", "Day": "23", "Hour": "12", "Minute": "44"}, {"Year": "2023", "Month": "12", "Day": "23", "Hour": "1", "Minute": "10"}, {"Year": "2023", "Month": "12", "Day": "4"}], "PublicationStatus": "epublish", "ArticleIdList": ["38137439", "PMC10740651", "10.3390/biomedicines11123218", "biomedicines11123218"]}}], "PubmedBookArticle": []}